Matches in SemOpenAlex for { <https://semopenalex.org/work/W2058888958> ?p ?o ?g. }
Showing items 1 to 99 of
99
with 100 items per page.
- W2058888958 endingPage "1932" @default.
- W2058888958 startingPage "1930" @default.
- W2058888958 abstract "Since 1999, a new immunosuppressive drug was administered to renal transplant patients. The SRL molecule acts by blocking post-receptor signal transduction of interleukin-2 (IL-2) interacting with a family of intracellular binding proteins termed immunophilins FKBPs. Among these FKBPs, FK506 12-kd binding protein is the most relevant. SRL is an immunosuppressive drug. Therefore it can inhibit the immune system; at the same time the drug is not nephrotoxic, neurotoxic, and without diabetogenic effects. Among 285 patients who underwent liver transplantation, 27 took Sirolimus as monotherapy. Immunosuppressive treatment upto cyclosporine (CsA) or tacrolimus (FK) associated with steroids (methylprednisolone) and mycophenolate Mofetil (MMF) was initiated among subjects with pre-transplant renal failure. SRL was administered as monotherapy for patients who developed nephrotoxicity, or neurotoxicity, or diabetes. Moreover, patients affected by multifocal HCC who did not meet the Milan criteria or patients who developed Kaposi’s Sarcoma were prescribed SRL monotherapy. Nephrotoxicity occurred in 14 patients with mean serum creatinine level 2.2 mg/dl. Eleven patients with real failure showed significant improvements after a mean period of 28 days of SRL monotherapy (range: 6–45 days). The mean creatinine serum level after treatment with SRL monotherapy was 1.0 mg/dl (range: 0.7–1.2 mg/dl). Neurotoxicity occurred in 4 patients with tremor, confusion, and agitation. Each patient had complete improvement of symptoms after a few days of Sirolimus monotherapy. Among Three patients who developed Kaposi’s Sarcoma, two underwent remission. One patient had diabetes due to calcineurin inhibitors, and one showed arterial hypertension not treatable with drugs. After the switch, we treated these patients with medications. Another important indication was HCC not meeting the Milan criteria. SRL monotherapy may be used to manage complication of calcineurin inhibitors or Kaposi’s Sarcoma." @default.
- W2058888958 created "2016-06-24" @default.
- W2058888958 creator A5000883758 @default.
- W2058888958 creator A5003061042 @default.
- W2058888958 creator A5007635069 @default.
- W2058888958 creator A5015059828 @default.
- W2058888958 creator A5015842968 @default.
- W2058888958 creator A5026052312 @default.
- W2058888958 creator A5027690349 @default.
- W2058888958 creator A5028700932 @default.
- W2058888958 creator A5043388086 @default.
- W2058888958 creator A5053986252 @default.
- W2058888958 date "2007-07-01" @default.
- W2058888958 modified "2023-09-25" @default.
- W2058888958 title "Sirolimus Monotherapy in Liver Transplantation" @default.
- W2058888958 cites W1570138415 @default.
- W2058888958 cites W1977867111 @default.
- W2058888958 cites W1982929789 @default.
- W2058888958 cites W2022850278 @default.
- W2058888958 cites W2060936723 @default.
- W2058888958 cites W2061792965 @default.
- W2058888958 cites W2084126045 @default.
- W2058888958 cites W2110872657 @default.
- W2058888958 cites W2138234324 @default.
- W2058888958 doi "https://doi.org/10.1016/j.transproceed.2007.07.018" @default.
- W2058888958 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17692656" @default.
- W2058888958 hasPublicationYear "2007" @default.
- W2058888958 type Work @default.
- W2058888958 sameAs 2058888958 @default.
- W2058888958 citedByCount "17" @default.
- W2058888958 countsByYear W20588889582012 @default.
- W2058888958 countsByYear W20588889582014 @default.
- W2058888958 countsByYear W20588889582015 @default.
- W2058888958 countsByYear W20588889582016 @default.
- W2058888958 countsByYear W20588889582020 @default.
- W2058888958 countsByYear W20588889582023 @default.
- W2058888958 crossrefType "journal-article" @default.
- W2058888958 hasAuthorship W2058888958A5000883758 @default.
- W2058888958 hasAuthorship W2058888958A5003061042 @default.
- W2058888958 hasAuthorship W2058888958A5007635069 @default.
- W2058888958 hasAuthorship W2058888958A5015059828 @default.
- W2058888958 hasAuthorship W2058888958A5015842968 @default.
- W2058888958 hasAuthorship W2058888958A5026052312 @default.
- W2058888958 hasAuthorship W2058888958A5027690349 @default.
- W2058888958 hasAuthorship W2058888958A5028700932 @default.
- W2058888958 hasAuthorship W2058888958A5043388086 @default.
- W2058888958 hasAuthorship W2058888958A5053986252 @default.
- W2058888958 hasConcept C126189478 @default.
- W2058888958 hasConcept C126322002 @default.
- W2058888958 hasConcept C126894567 @default.
- W2058888958 hasConcept C128057223 @default.
- W2058888958 hasConcept C2777921159 @default.
- W2058888958 hasConcept C2779609443 @default.
- W2058888958 hasConcept C2779699572 @default.
- W2058888958 hasConcept C2780252810 @default.
- W2058888958 hasConcept C2780306776 @default.
- W2058888958 hasConcept C2909675724 @default.
- W2058888958 hasConcept C2911091166 @default.
- W2058888958 hasConcept C29730261 @default.
- W2058888958 hasConcept C71924100 @default.
- W2058888958 hasConcept C90924648 @default.
- W2058888958 hasConcept C98274493 @default.
- W2058888958 hasConceptScore W2058888958C126189478 @default.
- W2058888958 hasConceptScore W2058888958C126322002 @default.
- W2058888958 hasConceptScore W2058888958C126894567 @default.
- W2058888958 hasConceptScore W2058888958C128057223 @default.
- W2058888958 hasConceptScore W2058888958C2777921159 @default.
- W2058888958 hasConceptScore W2058888958C2779609443 @default.
- W2058888958 hasConceptScore W2058888958C2779699572 @default.
- W2058888958 hasConceptScore W2058888958C2780252810 @default.
- W2058888958 hasConceptScore W2058888958C2780306776 @default.
- W2058888958 hasConceptScore W2058888958C2909675724 @default.
- W2058888958 hasConceptScore W2058888958C2911091166 @default.
- W2058888958 hasConceptScore W2058888958C29730261 @default.
- W2058888958 hasConceptScore W2058888958C71924100 @default.
- W2058888958 hasConceptScore W2058888958C90924648 @default.
- W2058888958 hasConceptScore W2058888958C98274493 @default.
- W2058888958 hasIssue "6" @default.
- W2058888958 hasLocation W20588889581 @default.
- W2058888958 hasLocation W20588889582 @default.
- W2058888958 hasOpenAccess W2058888958 @default.
- W2058888958 hasPrimaryLocation W20588889581 @default.
- W2058888958 hasRelatedWork W1966785288 @default.
- W2058888958 hasRelatedWork W2002510144 @default.
- W2058888958 hasRelatedWork W2017985233 @default.
- W2058888958 hasRelatedWork W2055110705 @default.
- W2058888958 hasRelatedWork W2328872699 @default.
- W2058888958 hasRelatedWork W2332638576 @default.
- W2058888958 hasRelatedWork W2512460450 @default.
- W2058888958 hasRelatedWork W2736541053 @default.
- W2058888958 hasRelatedWork W2765214489 @default.
- W2058888958 hasRelatedWork W4213432307 @default.
- W2058888958 hasVolume "39" @default.
- W2058888958 isParatext "false" @default.
- W2058888958 isRetracted "false" @default.
- W2058888958 magId "2058888958" @default.
- W2058888958 workType "article" @default.